League Notes

Miles’ Future In Question After ATP Drug Revelations

In London, Stephen Bierley writes that ATP CEO Mark Miles' future "is under threat along with the credibility" of the ATP after this week's drug revelations, in which the ATP "failed to prevent its specialist sports medicine staff from routinely handing out 'contaminated' supplements." World Anti-Doping Agency COO David Howman said he is "disturbed, disappointed and troubled about the conclusions reached," and added, "We don't have any jurisdiction at present, but it is our intention to make a formal proposal to the ATP" (London GUARDIAN, 7/11). ATP player Bohdan Ulihrach, who was reinstated this week after serving "nine months of a two-year suspension" for testing positive for a banned substance which may have been provided by the ATP is "considering a lawsuit" against the ATP (TENNIS WEEK, 7/12).

CART: AUTOWEEK reports that while Canadian promoter Norm Legault, CART team Owner Craig Pollock and CART COO David Clare have each been rumored as replacements for CART CEO Chris Pook, "chances are great that he's not about to be fired." There is "little substance in the buzz about Pook's imminent replacement, and none of it is coming from inside CART. Pook is not likely to extend his contract with CART," which runs through '04, for "anything other than a consulting role, and he is laying the groundwork for his eventual departure. But finding a replacement is not at the top of his to-do list" (AUTOWEEK, 7/7 issue).

NYRA: In N.Y., Mahoney & Bossert report that NYRA Chair Barry Schwartz yesterday "publicly chided" NYRA President Terry Meyocks' for his "inappropriate" defense of a five-year, $420,000 deferred compensation package given to former NYRA Chair Kenneth Noe. Meyocks told the Albany Times Union that the compensation package was "not anybody's business." Schwartz said yesterday, "The public has a stake and an interest in any matter that affects NYRA's financial bottom line" (N.Y. DAILY NEWS, 7/11).